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Mucosal vaccines created on the base of transgenic plants reacting with mucosal layers of the 
intestines and other organs are considered to be the perspective method of the vaccination. These 
vaccines   induce   both   mucosal   and   general   humoral   immunogenicity   after   the   peroral 
administration. The folding of antigenic proteins synthesizing in plants occurs via eukaryotic type 
and has advantages before yeast and prokaryotic platforms. This feature results to more adequate 
synthesis of antibodies against pathogens and to the interaction with effector molecules of 
complement. Earlier we together with The State Scientific Center “Vector”, Institute of chemical 
biology and fundamental medicine SB RAS and Dr R.Hammond from Laboratory of Plant Pathology 
(Maryland, USA) created two candidate vaccines : one of them against AIDS (HIV-1) and hepatitis B 
on the base of the chimeric gene TBI-HBS, encoding simultaneously 9 antigenic determinants of 
HIV-1 and the main surface antigen of hepatitis B (HBsAg). The second candidate vaccine was 
created against hepatitis B on the base of the genetic construct with the gene preS2-S encoding 
the synthesis of two subunits of the main surface antigen of hepatitis B and the signal peptide 
HDEL which directed antigens for the accumulation on ER. Both vaccines were tested on mice and 
confirmed their immunogenicity as the pronounced antibodies response. Twice vaccinated mice 
maintained the antibodies response during 11 months after there was little tendency to lowering. 
It was established that transgenic plants – vaccines (tomato) kept the capability to the synthesis of 
antigenic determinants in seven seed generations during 7 years. The results of the development 
of the mucosal vaccine against cervical carcinoma (carcinoma of uterine cervix) evoked by human 
papillomaviruses of high oncogenic risks were presented in this report. We created the genetic 
construct consisting of 35S CaMV promoter, Ώ (omega) leader of TMV, the target gene HPV16 L1 
and the nos terminator. The target gene HPV16 L1 of the most oncogenic type 16 of human 
papillomavirus was choosen as the object. Different procedures of the plant transformation were 
elaborated   and   the   transgenic   plants   synthesizing   the   antigenic   protein   L1   of   human 
papillomavirus of type 16 were obtained. The insertion and the expression of the target gene were 
controlled by northern blotting, the synthesis of antigenic protein HPV16 L1 was determined by 
ELISA and western blot. The antigenic protein of HPV16 L1 was synthesized in amount of 20 – 50 
ng/mg of total soluble proteins in tomato transgenic plants. The results of the examination of the 
immunogenicity of the vaccine obtained by means of the peroral immunization of mice were 
showed in the report. Therefore it was demonstrated the principal opportunity of the creation of 
mucosal vaccines on the base of transgenic plants against several dangerous diseases.
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